<p>以色列，Neve Yarak，2026 年 1 月 5 日（GLOBE NEWSWIRE）-- N2OFF, Inc.（納斯達克：NITO）（“N2OFF” 和 “公司”）是一家藥物發現公司，同時投資於基於 RTB（Ready to Build）商業模式的太陽能資產，宣佈通過與 Solterra Renewable Energy Ltd.（“Solterra”）的合作，推動其歐洲投資組合的發展。正如 2025 年 12 月 29 日所宣佈的，德國項目的關鍵里程碑，包括太陽能光伏和儲能資產，已降低了許可風險，通過智能資本部署釋放了價值，併為項目提供了引人注目的貨幣化選擇。</p>
<p><strong>投資者重點</strong></p>
<ul>
<li>降低核心歐洲資產的許可和監管風險</li>
<li>提前支付 34 萬美元，並在項目利潤份額中獲得有利條款</li>
<li>通過對開發經濟的嚴格重新談判，實現約 170 萬美元的項目級價值創造</li>
<li>增強的貨幣化選擇，多個高可見度的價值實現路徑將於 2026 年下半年開始</li>
</ul>
<p><strong>德國更新：預計 2026 年第三季度獲得批准，已確保節省</strong></p>
<p>N2OFF 在德國的旗艦太陽能項目已進入許可流程的最後階段，並穩步朝着預計在 2026 年第三季度獲得批准的目標前進。</p>
<p>第一次公眾諮詢階段即將完成，目前沒有反對意見或重大修改請求，這強烈表明了監管一致性、社區接受度和規劃完整性。最終諮詢階段的草案區域規劃提交定於 2026 年 1 月底假期後進行，保持了明確的發展時間表。</p>
<p>作為主動價值優化的示範，Solterra 表示上週已執行了開發協議的修訂。Solterra 將獲得約 34 萬美元的預付款，以加快進度，作為交換，開發費用每兆瓦減少 11,000 歐元，從而增加潛在利潤約 170 萬美元。</p>
<p>從資本配置的角度來看，此交易代表了對有限短期資本的高效再部署，以顯著改善長期項目經濟，增加嵌入的股權價值，並增強未來的退出或運營回報。</p>
<p><strong>戰略視角</strong></p>
<p>德國的最新進展推動了公司在 RTB 價值曲線上的歐洲投資組合。通過系統性地降低監管風險、收緊開發經濟並保持貨幣化靈活性，N2OFF 繼續將自己定位為專注於可擴展、基礎設施支持的價值創造的嚴謹資本配置者。</p>
<p><strong>關於 N2OFF Inc:</strong></p>
<p>N2OFF 擁有 MitoCareX Bio Ltd.的 100% 股份，這是一家專注於通過線粒體 SLC25 蛋白家族進行癌症治療和其他疾病藥物發現的藥物遞送公司。此外，N2OFF 採用了一種投資策略，專注於利用 RTB（Ready to Build）商業模式的歐洲可再生能源資產。該公司目前是三個歐盟國家四個太陽能項目的主要投資者，所有項目均由 Solterra Renewable Energy Ltd.引入，後者是 Solterra Energy Ltd.的全資子公司。</p>
<p>N2OFF 還控制約 98% 的 Save Foods Ltd.，這是一家以色列公司，專注於減少水果和蔬菜中病原體污染的後收穫處理技術。</p>
<p>欲瞭解更多信息，請訪問 www.n2off.com。</p>
<p><strong>前瞻性聲明：</strong></p>
<p>本新聞稿包含根據 1995 年《私人證券訴訟改革法案》和其他聯邦證券法的 “安全港” 條款的前瞻性聲明。諸如 “預計”、“預期”、“打算”、“計劃”、“相信”、“尋求”、“估計” 等詞語及其類似表達或變體旨在識別前瞻性聲明。由於這些聲明涉及未來事件並基於我們當前的預期，因此它們受到各種風險和不確定性的影響，包括我們與 Solterra Energy Ltd.的合作成功、進入未來項目的能力、我們成功進入太陽能光伏行業的能力、該行業的盈利能力以及增加產能的潛在附加價值。實際結果、表現或成就可能與本新聞稿中描述或暗示的內容有重大差異。本新聞稿中包含或暗示的前瞻性聲明受到其他風險和不確定性的影響，包括市場條件以及在 N2OFF 於 2025 年 3 月 31 日向 SEC 提交的 10-K 年度報告中討論的 “風險因素” 標題下的內容，以及任何後續向 SEC 提交的文件。除非法律另有要求，否則我們不承擔公開發布任何修訂前瞻性聲明的義務，以反映本日期之後的事件或情況，或反映意外事件的發生。提供網站的引用和鏈接僅為方便，網站上包含的信息不被納入本新聞稿。我們對第三方網站的內容不承擔任何責任。</p>
<p>投資者關係聯繫人：</p>
<p>Michal Efraty</p>
<p>michal@efraty.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeE9UYzFNeU0zTXpRME16TXlJelV3TURBMU16WTJOZz09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeE9UYzFNeU0zTXpRME16TXlJelV3TURBMU16WTJOZz09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/M2RhMzQ0OGQtMjgyOC00NmFmLTg4Y2QtNzZjYmFkOGZmZmQ2LTUwMDA1MzY2Ni0yMDI2LTAxLTA1LWVu/tiny/N2OFF-Inc-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/M2RhMzQ0OGQtMjgyOC00NmFmLTg4Y2QtNzZjYmFkOGZmZmQ2LTUwMDA1MzY2Ni0yMDI2LTAxLTA1LWVu/tiny/N2OFF-Inc-.png"/></p>

NITO

<p>N2OFF, Inc.（納斯達克代碼：NITO）已向 Solterra Renewable Energy Ltd.預付 34 萬美元，以確保其太陽能項目獲得更好的條款，這可能使項目利潤增加約 170 萬美元。該公司預計將在 2026 年第三季度獲得其旗艦德國太陽能項目的批准，降低了許可風險並增強了貨幣化選項。這一戰略舉措反映了 N2OFF 在歐洲可再生能源資產中專注於嚴格的資本配置和價值創造</p>

<p>Neve Yarak, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a drug discovery company that is also investing in solar energy assets based on the RTB (Ready to Build) business model, announced advancement in its European portfolio via its partnership with Solterra Renewable Energy Ltd. (“Solterra”). As announced on December 29, 2025, key milestones in Germany project, which includes solar energy PV and storage assets, have reduced permitting risks, unlocked value through smart capital deployment, and positioned projects for compelling monetization optionality.</p>
<div class="lb-trans"><p>以色列，Neve Yarak，2026 年 1 月 5 日（GLOBE NEWSWIRE）-- N2OFF, Inc.（納斯達克：NITO）（“N2OFF” 和 “公司”）是一家藥物發現公司，同時投資於基於 RTB（Ready to Build）商業模式的太陽能資產，宣佈通過與 Solterra Renewable Energy Ltd.（“Solterra”）的合作，推動其歐洲投資組合的發展。正如 2025 年 12 月 29 日所宣佈的，德國項目的關鍵里程碑，包括太陽能光伏和儲能資產，已降低了許可風險，通過智能資本部署釋放了價值，併為項目提供了引人注目的貨幣化選擇。</p>
</div><p><strong>Key Investor Highlights</strong></p>
<div class="lb-trans"><p><strong>投資者重點</strong></p>
</div><ul>
<li>Reduction in permitting and regulatory risk across core European assets</li>
<li>Advanced payment of $340,000 and receiving favourable terms in the project’s profit stake</li>
<li>Approximately $1.7 million in project-level value creation achieved through disciplined renegotiation of development economics</li>
<li>Enhanced monetization optionality, with multiple high-visibility pathways to value realization beginning in H2 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>降低核心歐洲資產的許可和監管風險</li>
<li>提前支付 34 萬美元，並在項目利潤份額中獲得有利條款</li>
<li>通過對開發經濟的嚴格重新談判，實現約 170 萬美元的項目級價值創造</li>
<li>增強的貨幣化選擇，多個高可見度的價值實現路徑將於 2026 年下半年開始</li>
</ul>
</div><p><strong>Germany Update: on track for Q3 2026 approval with savings secured</strong></p>
<div class="lb-trans"><p><strong>德國更新：預計 2026 年第三季度獲得批准，已確保節省</strong></p>
</div><p>N2OFF’s flagship German solar project has advanced into the final stages of the permitting process and remains firmly on track toward expected approval in Q3 2026.</p>
<div class="lb-trans"><p>N2OFF 在德國的旗艦太陽能項目已進入許可流程的最後階段，並穩步朝着預計在 2026 年第三季度獲得批准的目標前進。</p>
</div><p>The first public consultation phase is nearing completion with no objections or material modification requests to date, a strong indicator of regulatory alignment, community acceptance, and planning integrity. Submission of the draft zoning plan for the final consultation phase is scheduled for late January 2026 following the holiday period, maintaining a clear development timeline.</p>
<div class="lb-trans"><p>第一次公眾諮詢階段即將完成，目前沒有反對意見或重大修改請求，這強烈表明了監管一致性、社區接受度和規劃完整性。最終諮詢階段的草案區域規劃提交定於 2026 年 1 月底假期後進行，保持了明確的發展時間表。</p>
</div><p>In a demonstration of proactive value optimization, Solterra has indicated that an amendment to the development agreement was executed last week. Solterra will receive approximately $340,000 in advance funding to fuel faster progress, in exchange for a €11,000 per MW reduction in development fees, thereby increasing potential profit with approximately $ 1.7 million.</p>
<div class="lb-trans"><p>作為主動價值優化的示範，Solterra 表示上週已執行了開發協議的修訂。Solterra 將獲得約 34 萬美元的預付款，以加快進度，作為交換，開發費用每兆瓦減少 11,000 歐元，從而增加潛在利潤約 170 萬美元。</p>
</div><p>From a capital allocation perspective, this transaction represents a highly efficient redeployment of limited near-term capital to materially improve long-term project economics, increase embedded equity value, and enhance future exit or operating returns.</p>
<div class="lb-trans"><p>從資本配置的角度來看，此交易代表了對有限短期資本的高效再部署，以顯著改善長期項目經濟，增加嵌入的股權價值，並增強未來的退出或運營回報。</p>
</div><p><strong>Strategic Perspective</strong></p>
<div class="lb-trans"><p><strong>戰略視角</strong></p>
</div><p>The recent developments in Germany advance the Company’s European portfolio along the RTB value curve. By systematically reducing regulatory risk, tightening development economics, and preserving monetization flexibility, N2OFF continues to position itself as a disciplined capital allocator focused on scalable, infrastructure-backed value creation.</p>
<div class="lb-trans"><p>德國的最新進展推動了公司在 RTB 價值曲線上的歐洲投資組合。通過系統性地降低監管風險、收緊開發經濟並保持貨幣化靈活性，N2OFF 繼續將自己定位為專注於可擴展、基礎設施支持的價值創造的嚴謹資本配置者。</p>
</div><p><strong>About N2OFF Inc:</strong></p>
<div class="lb-trans"><p><strong>關於 N2OFF Inc:</strong></p>
</div><p>N2OFF owns 100% of MitoCareX Bio Ltd, a drug delivery company engaged in drug discovery targeting cancer therapeutics and other diseases through the mitochondrial SLC25 protein family. Additionally, N2OFF adopted an investment strategy focused on European renewable energy assets utilizing a RTB (Ready to Build ) business model. The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd</p>
<div class="lb-trans"><p>N2OFF 擁有 MitoCareX Bio Ltd.的 100% 股份，這是一家專注於通過線粒體 SLC25 蛋白家族進行癌症治療和其他疾病藥物發現的藥物遞送公司。此外，N2OFF 採用了一種投資策略，專注於利用 RTB（Ready to Build）商業模式的歐洲可再生能源資產。該公司目前是三個歐盟國家四個太陽能項目的主要投資者，所有項目均由 Solterra Renewable Energy Ltd.引入，後者是 Solterra Energy Ltd.的全資子公司。</p>
</div><p>N2OFF also controls approximately 98% of Save Foods Ltd., an Israeli company focused on post-harvest treatment technologies designed to reduce pathogen contamination in fruits and vegetables.</p>
<div class="lb-trans"><p>N2OFF 還控制約 98% 的 Save Foods Ltd.，這是一家以色列公司，專注於減少水果和蔬菜中病原體污染的後收穫處理技術。</p>
</div><p>For more information, please visit www.n2off.com.</p>
<div class="lb-trans"><p>欲瞭解更多信息，請訪問 www.n2off.com。</p>
</div><p><strong>Forward-looking Statements:</strong></p>
<div class="lb-trans"><p><strong>前瞻性聲明：</strong></p>
</div><p>This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on our current expectations, they are subject to various risks and uncertainties including the success of our collaboration with Solterra Energy Ltd., entry into future projects, our ability to successfully enter the solar PV sector, the profitability of such industry, and the potential added value of the increased capacity. Actual results, performance or achievements could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including market conditions as well as those discussed under the heading “Risk Factors” in N2OFF’s Annual Report on Form 10-K filed with the SEC on March 31, 2025, and in any subsequent filings with the SEC. Except as otherwise required by law, we undertake no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. We are not responsible for the contents of third-party websites.</p>
<div class="lb-trans"><p>本新聞稿包含根據 1995 年《私人證券訴訟改革法案》和其他聯邦證券法的 “安全港” 條款的前瞻性聲明。諸如 “預計”、“預期”、“打算”、“計劃”、“相信”、“尋求”、“估計” 等詞語及其類似表達或變體旨在識別前瞻性聲明。由於這些聲明涉及未來事件並基於我們當前的預期，因此它們受到各種風險和不確定性的影響，包括我們與 Solterra Energy Ltd.的合作成功、進入未來項目的能力、我們成功進入太陽能光伏行業的能力、該行業的盈利能力以及增加產能的潛在附加價值。實際結果、表現或成就可能與本新聞稿中描述或暗示的內容有重大差異。本新聞稿中包含或暗示的前瞻性聲明受到其他風險和不確定性的影響，包括市場條件以及在 N2OFF 於 2025 年 3 月 31 日向 SEC 提交的 10-K 年度報告中討論的 “風險因素” 標題下的內容，以及任何後續向 SEC 提交的文件。除非法律另有要求，否則我們不承擔公開發布任何修訂前瞻性聲明的義務，以反映本日期之後的事件或情況，或反映意外事件的發生。提供網站的引用和鏈接僅為方便，網站上包含的信息不被納入本新聞稿。我們對第三方網站的內容不承擔任何責任。</p>
</div><p>Investor Relations Contact:</p>
<div class="lb-trans"><p>投資者關係聯繫人：</p>
</div><p>Michal Efraty</p>
<div class="lb-trans"><p>Michal Efraty</p>
</div><p>michal@efraty.com</p>
<div class="lb-trans"><p>michal@efraty.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeE9UYzFNeU0zTXpRME16TXlJelV3TURBMU16WTJOZz09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTYxOTc1MyM3MzQ0MzMyIzUwMDA1MzY2Ng=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/M2RhMzQ0OGQtMjgyOC00NmFmLTg4Y2QtNzZjYmFkOGZmZmQ2LTUwMDA1MzY2Ni0yMDI2LTAxLTA1LWVu/tiny/N2OFF-Inc-.png" alt="" original-src="https://ml.globenewswire.com/media/M2RhMzQ0OGQtMjgyOC00NmFmLTg4Y2QtNzZjYmFkOGZmZmQ2LTUwMDA1MzY2Ni0yMDI2LTAxLTA1LWVu/tiny/N2OFF-Inc-.png"/></p>

N2OFF Advances $340,000 Payment to Gain Better Terms in Flag Solar Energy Initiative, Reflecting Approximately an Additional $1.7 Million in Project Profit Stake | NITO Stock News

N2OFF 預付 34 萬美元以獲得更優惠的條款，這反映出在 Flag 太陽能項目中額外約 170 萬美元的項目利潤份額 | NITO 股票新聞